RESUMEN
A retrospective case-controlled analysis was performed to identify drug candidates in the current use that may prevent colorectal cancer, outside of aspirin. A total of 37,510 patients aged ≥20 years were assessed to identify subjects who had been diagnosed with colorectal cancer by colonoscopy without a previous diagnosis of colorectal cancer, inflammatory bowel disease (IBD), or gastrointestinal symptoms; 1,560 patients were identified who were diagnosed with colorectal cancer by colonoscopy. The patients with colorectal cancer were matched with 1,560 age, gender, family history of colorectal cancer and comorbidity-matched control patients who were not diagnosed with colorectal cancer at colonoscopy. The medication histories were compared between the two groups. Next, candidate drugs that were more frequently used by the control patients were selected and their effects on human colorectal cancer cell lines in vitro and an inflammation-induced mouse model of colorectal cancer were tested. Putative colorectal cancer preventative agents were identified, including aspirin, vitamin D, vitamin B, vitamin C, vitamin E, xanthine oxidase inhibitor, alpha-blockers, angiotensin receptor blocker, nateglinide, probiotics, thienopyridine, folic acid, nitrovasodilators, bisphosphonates, calcium channel blockers, steroids, and statins (P < 0.05). Alpha-blockers and xanthine oxidase inhibitors were selected for further study because these agents have not been analyzed previously as factors that may affect colorectal cancer outcomes. In vitro doxazosin (alpha-blocker), but not febuxostat (xanthine oxidase inhibitor), suppressed the proliferation of human colorectal cancer cells. Doxazosin also decreased tumorigenesis in an AOM/DSS mouse colorectal cancer model. Alpha-blockers may prevent colorectal cancer.
Asunto(s)
Antagonistas de Receptores Adrenérgicos alfa 1/farmacología , Anticarcinógenos/farmacología , Proliferación Celular/efectos de los fármacos , Neoplasias Colorrectales/prevención & control , Doxazosina/farmacología , Anciano , Anciano de 80 o más Años , Animales , Antiinflamatorios no Esteroideos/farmacología , Apoptosis/efectos de los fármacos , Aspirina/farmacología , Estudios de Casos y Controles , Neoplasias Colorrectales/metabolismo , Neoplasias Colorrectales/patología , Febuxostat/farmacología , Femenino , Supresores de la Gota/farmacología , Humanos , Masculino , Ratones , Ratones Endogámicos C57BL , Persona de Mediana Edad , Pronóstico , Estudios Retrospectivos , Células Tumorales CultivadasRESUMEN
Epigonus okamotoi Fricke, 2017 was originally described on the basis of a single specimen collected from New Britain, Papua New Guinea during one of the exploratory cruises (campaign: MADEEP) in 2014 organized under the Tropical Deep-Sea Benthos program. However, there are no clear differences in the meristic and morphometric characters between the holotype of the new species and specimens of E. draco Okamoto, 2015, including two additional specimens of the species found in the ichthyological collections in the NTUM. The genetic distance (p-distance) between the two "species" at the COI locus was negligible. Accordingly, the holotype of E. okamotoi is considered to be a specimen of E. draco, and the former nominal species is reduced to a junior synonym of E. draco. In addition, we rediagnose and report new distributional records for E. atherinoides (Gilbert, 1905) and E. lifouensis Okamoto Motomura, 2013 in the West Pacific.
Asunto(s)
Perciformes , Animales , Papúa Nueva GuineaRESUMEN
The fishes of the genus Epigonus Rafinesque, 1810 in the Western Indian Ocean (including the Red Sea and the Gulf of Aden) are reviewed. Twelve species of the genus are recognized: Epigonus angustifrons Abramov Manilo, 1987; E. denticulatus Dieuzeide, 1950; E. elongatus Parin Abramov, 1986; E. exodon Okamoto Motomura, 2012; E. lenimen (Whitley, 1935); E. macrops (Brauer, 1906); E. marimonticolus Parin Abramov, 1986; E. marisrubri Krupp, Zajonz Khalaf, 2009; E. pectinifer Mayer, 1974; E. robustus (Barnard, 1927); E. telescopus (Risso, 1810); E. waltersensis Parin Abramov, 1986, and two new species, E. bispinosus n. sp. and E. idai n. sp. Epigonus bispinosus and E. idai belong to the E. constanciae group, defined as having a pungent opercular spine, more than 45 pored lateral-line scales, and lacking an isolated dorsal fin spine between the first- and second dorsal fins. Epigonus bispinosus differs from other members of the group in having two small spines on the symphysis of lower jaw, a pair of ribs on the last abdominal vertebra, 10 + 15 vertebrae, 31-33 gill rakers and lacking a maxillary mustache-like process. Epigonus idai differs from other members of the group in having a pair of ribs on the last abdominal vertebra, 4-5 tiny projections present on symphysis of lower jaw, 10 + 15 vertebrae, strongly ctenoid scales, and 28-29 gill rakers, and in lacking a maxillary mustache-like process. A key to the species, photographs, diagnoses, and distributions in the Western Indian Ocean are given.
Asunto(s)
Perciformes , Distribución Animal , Animales , Peces , Océano Índico , YemenRESUMEN
The Pelagia is a recently delineated group of fishes, comprising fifteen families formerly placed in six perciform suborders. The Pelagia was lately recognized as it encompasses huge morphological diversity and only in the last few years have large-scale molecular phylogenetic studies been undertaken that could unite such morphologically disparate lineages. Due to the recent erection of Pelagia, the composition of the taxon is not entirely certain. Five families of the former perciform suborder Stromateoidei have been identified as pelagians. However, the sixth stromateoid subfamily Amarsipidae is a rare monotypic family that has distinctive meristic and morphological characteristics from that of other stromateoids such as the lack of a pharyngeal sac. We examine molecular data generated from the sole species in Amarsipidae, Amarsipus carlsbergi, and demonstrate that it is clearly nested within Pelagia. As with two previous studies that have the breadth of sampling to evaluate pelagian intra-relationships, we find high support for monophyly of most family-level taxonomic units but statistical support for early-branching nodes in the pelagian tree is very low. We conduct the first analyses of Pelagia incorporating the multispecies coalescent and are limited by a high degree of missing loci, or, incomplete taxon sampling. The high degree of missing data across a complete sampling of pelagian lineages along with the deep time scale and rapid radiation of the lineage contribute to poor resolution of early-branching relationships within Pelagia that cannot be resolved with current data sets. Currently available data are either mitochondrial genomes or a super matrix of relatively few loci with a high degree of missing data. A new and independent dataset of numerous phylogenetic loci derived from high-throughput sequencing technology may reduce uncertainty within the Pelagia and provide insights into this adaptive radiation.
Asunto(s)
Peces/clasificación , Peces/genética , Sitios Genéticos , Filogenia , Animales , Secuencia de Bases , Funciones de Verosimilitud , Alineación de Secuencia , Análisis de Secuencia de ADNRESUMEN
A new species of ptereleotrine dartfish, Navigobius asayake, is described based on four specimens (45.0-52.1 mm in standard length: SL) collected from off the Satsuma Peninsula and Tanegashima island, Kagoshima, southern Japan. It is distinguished from other congeners by the following combination of characters: second dorsal-fin rays I, 18-19; anal-fin rays I, 19; pectoral-fin rays 21-22; gill rakers 5-6 + 13-15; head length 25.1-26.4% SL; eye diameter 8.6-10.0% SL; pelvic-fin length 15.2-16.1% SL; and a well-developed yellow stripe extending from behind upper part of eye to beneath first dorsal fin.
Asunto(s)
Perciformes , Animales , Branquias , Cabeza , Islas , JapónRESUMEN
BACKGROUND: Among patients with obscure gastrointestinal bleeding (OGIB), endoscopic ulcerative lesions in the small bowel have diverse etiologies and often cause rebleeding. Certain characteristics of patients or ulcerations may be reasonable indications for diagnostic balloon-assisted endoscopy (BAE) to assess etiology and may be risks of rebleeding; however, these characteristics are unclear. We aimed to elucidate appropriate indications for diagnostic BAE and predictors of long-term rebleeding in patients with small bowel ulcerative lesions. METHODS: We conducted a multicenter retrospective cohort study of 68 patients with OGIB, in whom small bowel ulcerative lesions were detected by capsule endoscopy (n = 60) and/or BAE (n = 43). Patients' characteristics, including medications and endoscopic findings, were evaluated. Predictors of the need for diagnostic BAE to determine ulceration etiology were identified by logistic regression analysis. Rebleeding risks were evaluated using Cox proportional hazards analysis. RESULTS: Single ulcerations were diagnosed in 26 patients, and multiple ulcerations were diagnosed in 42 patients. Among 43 patients who underwent BAE, ulceration etiology was identified in 12 (28%) patients. In the etiology identification, BAE was more useful for a single ulceration than for multiple ulcerations (P < 0.001). Among the 68 patients, rebleeding occurred in 14 (21%) patients during a mean follow-up period of 17 months. Aspirin use and multiple ulcerations were significant predictors of rebleeding (P < 0.05). CONCLUSIONS: When we manage small bowel ulcerative lesions in OGIB patients, a single ulceration is a reasonable indication for the diagnostic BAE. The rebleeding rate was lower for single ulcerations than for multiple ulcerations.
Asunto(s)
Endoscopía Gastrointestinal/métodos , Intestino Delgado , Úlcera Péptica Hemorrágica/diagnóstico , Úlcera Péptica Hemorrágica/etiología , Anciano , Aspirina/efectos adversos , Endoscopía Capsular , Estudios de Cohortes , Femenino , Estudios de Seguimiento , Predicción , Humanos , Modelos Logísticos , Masculino , Modelos de Riesgos Proporcionales , Recurrencia , Estudios RetrospectivosRESUMEN
BACKGROUND: There are limited colonoscopy-based cohort data concerning the effectiveness of colonoscopy in reducing colorectal cancer deaths. The aim of this study was to clarify whether colonoscopy reduces colorectal cancer mortality. METHODS: A cohort of 18,816 patients who underwent colonoscopy without a diagnosis of colorectal cancer between 2001 and 2010 at high colonoscopy procedure volume centers was selected. Patient characteristics and colonoscopy findings were assessed. The main endpoint was colorectal cancer death (all, right-sided, and left-sided cancers), and data were censored at the time of the final visit or the final colonoscopy. The standardized all colorectal, colon, and rectal cancer mortality rates were estimated with reference to those of the general Japanese population. Additional outcome was all- cause death and the standardized all-cause mortality rate was also estimated. RESULTS: The total observed person-year mortality for colorectal cancer was 67,119. Of these, 4, 3, and 1 patients died from colorectal, colon, and rectal cancers, respectively; these values were significantly lower than the number of expected deaths in the general population, estimated to be 53.1, 34.0, and 19.1, respectively. The standardized mortalities for all colorectal, colon, and rectal cancers were 0.08 (95% confidence interval (CI), 0.02-0.17), 0.09 (95% CI, 0.02-0.22), and 0.05 (95% CI, 0.0002-0.21), respectively. There were 586 all-cause deaths (3.11%) during the observation period. The standardized all-cause mortality ratios were 0.22 (95% CI, 0.206-0.23). CONCLUSIONS: The colorectal cancer mortality of patients who received colonoscopy without colorectal cancer diagnosis decreased significantly compared with that of individuals in the general population. These results were compatible even in patients with right-sided colon cancer.
Asunto(s)
Colonoscopía , Neoplasias Colorrectales/mortalidad , Anciano , Anciano de 80 o más Años , Estudios de Cohortes , Femenino , Estudios de Seguimiento , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Factores de RiesgoRESUMEN
It is often difficult to insert a long intestinal tube (LT) in patients with small bowel obstruction (SBO). We developed a novel technique for inserting an LT without endoscopy called nonendoscopic over-the-wire method via short nasogastric tube (NEWSt). We evaluated the efficacy and safety of NEWSt.We performed a retrospective study of patients who underwent LT insertion for SBO without any indications of strangulation with either NEWSt (nâ=â16) or endoscopy (nâ=â17) between November 2011 and February 2015 at our hospital. Univariate analysis was used to assess the success rate of LT placement beyond the duodenojejunal flexure, time required for the procedure, clinical outcomes, and adverse events.The success rate was 100% in both groups. Procedure time was numerically, but not statistically, shorter in the NEWSt group compared with the endoscopy group (24â±â13 vs 30â±â13âmin; Pâ=â0.174). There were no statistically significant differences between the 2 groups in terms of surgery rate (31% vs 12%; Pâ=â0.225), fasting period (11.3â±â6.3 vs 9.9â±â4.5 days; Pâ=â0.482), hospital stay (26.4â±â22.1 vs 18.7â±â7.0 days; Pâ=â0.194), and recurrence rate (19% vs 24%; Pâ=â1.0). No serious adverse event was observed in the NEWSt group, whereas serious aspiration pneumonia was observed in 2 patients after LT insertion in the endoscopy group.Without endoscopy, NEWSt enabled the high success rate and the short procedure time for the LT insertion. Prospective, randomized controlled trials are needed.
Asunto(s)
Obstrucción Intestinal/cirugía , Intestino Delgado/cirugía , Intubación Gastrointestinal/instrumentación , Anciano , Femenino , Humanos , Masculino , Tempo Operativo , Estudios Retrospectivos , Tomografía Computarizada por Rayos X , Resultado del TratamientoRESUMEN
OBJECTIVE: Vonoprazan is a potassium-competitive acid blocker, a new type of acid-suppressing drug, and has recently become available for peptic ulcers, gastroesophageal reflux disease, and Helicobacter pylori (H. pylori) eradication. Its efficacy for H. pylori eradication has been reported. However, the evidence for its efficacy and feasibility remains limited. We aimed to compare the feasibility, effectiveness and safety of vonoprazan-based triple therapy with conventional proton pump inhibitor (PPI)-based triple therapy in multicenter clinical practice. METHODS: We performed a multicenter retrospective study on patients receiving first-line H. pylori eradication therapy between March 2013 and November 2015 with either vonoprazan-based triple therapy or conventional PPI-based triple therapy. RESULTS: A total of 2715 patients aged 63.0 ± 12.1 years (1412 [52.0%] males) were analyzed. Eradication rates were 87.2% (368/422) for vonoprazan-based therapy and 72.4% (1661/2293) for conventional PPI-based therapy (P < 0.01). Among the former group, there were 10 cases of diarrhea, six of nausea/vomiting, and five of rash, but the rates of these adverse events were similar to those in the conventional PPI group. CONCLUSION: Vonoprazan-based triple therapy is feasible, and has a higher rate for H. pylori eradication than conventional PPI as a first-line regimen.
Asunto(s)
Antibacterianos/uso terapéutico , Infecciones por Helicobacter/tratamiento farmacológico , Helicobacter pylori/efectos de los fármacos , Inhibidores de la Bomba de Protones/uso terapéutico , Pirroles/uso terapéutico , Sulfonamidas/uso terapéutico , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Amoxicilina/uso terapéutico , Antiulcerosos/uso terapéutico , Claritromicina/uso terapéutico , Quimioterapia Combinada , Estudios de Factibilidad , Femenino , Infecciones por Helicobacter/diagnóstico , Humanos , Masculino , Persona de Mediana Edad , Inhibidores de la Bomba de Protones/efectos adversos , Pirroles/efectos adversos , Estudios Retrospectivos , Sulfonamidas/efectos adversos , Resultado del Tratamiento , Adulto JovenRESUMEN
BACKGROUND: Middle gastrointestinal bleeding (MGIB) risk has not been fully investigated due to its extremely rare occurrence and the need for multiple endoscopies to exclude upper and lower gastrointestinal bleeding. This study investigated whether MGIB is associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs), low-dose aspirin (LDA), thienopyridines, anticoagulants, and proton-pump inhibitors (PPIs), and whether PPI use affects the interactions between MGIB and antithrombotic drugs. METHODS: In this multicenter, hospital-based, case-control study, 400 patients underwent upper and lower endoscopy, 80 had acute overt MGIB and 320 had no bleeding and were matched for age and sex as controls (1:4). MGIB was additionally evaluated by capsule and/or double-balloon endoscopy, after excluding upper and lower GI bleeding. Adjusted odds ratios (AOR) for MGIB risk were calculated using conditional logistic regression. To estimate the propensity score, we employed a logistic regression model for PPI use. RESULTS: In patients with MGIB, mean hemoglobin level was 9.4 g/dL, and 28 patients (35%) received blood transfusions. Factors significantly associated with MGIB were chronic kidney disease (p<0.001), liver cirrhosis (p = 0.034), NSAIDs (p<0.001), thienopyridines (p<0.001), anticoagulants (p = 0.002), and PPIs (p<0.001). After adjusting for these factors, NSAIDs (AOR, 2.5; p = 0.018), thienopyridines (AOR, 3.2; p = 0.015), anticoagulants (AOR, 4.3; p = 0.028), and PPIs (AOR; 2.0; p = 0.021) were independently associated with MGIB. After adjusting for propensity score, the use of PPIs remained an independent risk factors for MGIB (AOR, 1.94; p = 0.034). No significant interactions were observed between PPIs and NSAIDs (AOR, 0.7; p = 0.637), LDA (AOR, 0.3; p = 0.112), thienopyridine (AOR, 0.7, p = 0.671), or anticoagulants (AOR, 0.5; p = 0.545). CONCLUSIONS: One-third of patients with acute small intestinal bleeding required blood transfusion. NSAIDs, thienopyridines, anticoagulants, and PPIs increased the risk of acute small intestinal bleeding. However, there were no significant interactions found between antithrombotic drugs and PPI use for bleeding risk.
Asunto(s)
Antiinflamatorios no Esteroideos/efectos adversos , Anticoagulantes/efectos adversos , Aspirina/efectos adversos , Hemorragia Gastrointestinal/inducido químicamente , Inhibidores de Agregación Plaquetaria/efectos adversos , Inhibidores de la Bomba de Protones/efectos adversos , Adulto , Anciano , Anciano de 80 o más Años , Antiinflamatorios no Esteroideos/uso terapéutico , Anticoagulantes/uso terapéutico , Aspirina/uso terapéutico , Estudios de Casos y Controles , Femenino , Humanos , Masculino , Persona de Mediana Edad , Inhibidores de Agregación Plaquetaria/uso terapéutico , Inhibidores de la Bomba de Protones/uso terapéutico , Estudios Retrospectivos , Factores de Riesgo , Adulto JovenRESUMEN
BACKGROUND AND AIM: The long-term recurrence rate of patients with obscure gastrointestinal bleeding (OGIB) who underwent video capsule endoscopy (VCE) remains unknown. Our study aimed to identify the cumulative incidence of rebleeding, develop a predictive model of rebleeding, and evaluate whether the model can be applied in other outcomes among patients with OGIB. METHODS: We conducted a multicenter retrospective cohort study of 320 patients with OGIB who underwent VCE between 2009 and 2014. A rebleeding model was developed using multivariate Cox proportional hazards analysis and evaluated using Harrell's c-index. RESULTS: Rebleeding occurred in 43 patients (13.4%) during a mean follow-up period of 18.3 (standard error, 0.9) months. The rebleeding sources were the small intestine (n = 17), extra-small intestine (n = 13), and unknown (n = 13). The cumulative incidence of rebleeding was 11.0% at 12 months and 35.3% at 60 months. Multivariate analysis revealed that female gender, liver cirrhosis, warfarin use, overt bleeding, and positive VCE findings were significant predictors of rebleeding. The rebleeding rate was 0% in patients with no predictors and 40% in patients with full predictors (P < 0.01). The model presented a high predictive accuracy (c-statistic, 0.733). Patients with higher predictors exhibited higher transfusion requirements, longer length of stay, and higher mortality (P < 0.01). CONCLUSION: The cumulative incidence of rebleeding at 12 and 60 months was 11.0% and 35.3%, respectively. Five factors enable prediction of not only rebleeding but also transfusion requirements, length of stay, and death in OGIB patients.
Asunto(s)
Hemorragia Gastrointestinal/epidemiología , Anciano , Transfusión Sanguínea/estadística & datos numéricos , Endoscopía Capsular , Estudios de Cohortes , Bases de Datos como Asunto , Femenino , Estudios de Seguimiento , Predicción , Hemorragia Gastrointestinal/diagnóstico por imagen , Hemorragia Gastrointestinal/mortalidad , Hemorragia Gastrointestinal/terapia , Humanos , Incidencia , Tiempo de Internación/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Modelos Estadísticos , Estudios Multicéntricos como Asunto , Modelos de Riesgos Proporcionales , Recurrencia , Estudios Retrospectivos , Factores de TiempoRESUMEN
BACKGROUND: Endoscopic submucosal dissection (ESD) of early gastric cancer is a minimally invasive procedure. However, the risk for metachronous cancers after successful cancer treatment remains high and the risk factors for metachronous cancers have not been elucidated. OBJECTIVE: To evaluate the risk factors for metachronous gastric cancers after ESD with a long-term follow-up. METHODS: A total of 155 consecutive patients (119 men, 36 women, mean age 68.9 years) were treated with ESD between September 2000 and September 2009. Biopsy specimens were obtained from the greater curvature of the antrum and middle corpus to evaluate gastric mucosal status, including Helicobacter pylori, intestinal metaplasia (IM) and neutrophil infiltration (NI) before ESD. Follow-up endoscopy after ESD was scheduled at two and six months, one year and annually thereafter. H pylori eradication was recommended when possible. RESULTS: The median follow-up period was 4.2 years. Metachronous gastric cancers were found in 23 of 155 patients (3.5% per year). No local recurrences were observed. The cumulative incidence of metachronous gastric cancer was significantly high in IM and NI in the corpus (P=0.0093 and P=0.0025, respectively [log-rank test]). The ORs for IM and NI in the corpus were 2.65 and 3.06, respectively, according to the Cox proportional hazards model (P=0.024 and P=0.0091, respectively). CONCLUSIONS: The presence of IM and NI in the corpus was closely related to the development of metachronous gastric cancer after ESD.
Asunto(s)
Disección/efectos adversos , Intestinos/patología , Neoplasias Primarias Secundarias/epidemiología , Infiltración Neutrófila , Neoplasias Gástricas/inmunología , Anciano , Anciano de 80 o más Años , Disección/métodos , Femenino , Estudios de Seguimiento , Mucosa Gástrica/cirugía , Gastroscopía , Helicobacter pylori , Humanos , Masculino , Metaplasia , Persona de Mediana Edad , Neoplasias Gástricas/patología , Neoplasias Gástricas/cirugíaRESUMEN
BACKGROUND AND AIM: The technique of endoscopic submucosal dissection (ESD) was introduced to obtain en bloc specimens of large early gastrointestinal neoplasms. The drawback of ESD is its technical difficulty and, consequently, its higher rate of complication. In this multicenter study, we investigated the therapeutic outcomes of ESD in consecutive patients. METHODS: From January 2002 to December 2008, 485 early gastric neoplasms in 418 patients were consecutively treated by using ESD procedure performed by 6 endoscopists in 4 institutions in Tokyo. Demorgraphics, tumor location, therapeutic outcomes, and complication rates were analyzed. RESULTS: The rates of en bloc resection, complete en bloc resection, submucosal invasion, and piecemeal resection were 93.6%, 85.4%, 10.9%, and 5.4%, respectively. In multivariate analysis, the en bloc resection rate was independently lower in lesions in upper portion than in lower portion (P<0.01), lower in larger lesions (>30 mm, P<0.05; 20 to 30 mm, P<0.05), and lower in lesions with a scar (P<0.01). Delayed bleeding occurrence was independently high in larger lesions (>30 mm, P<0.01; 20 to 29 mm, P<0.01) than in small lesions (<20 mm). Institution and endoscopists were not risk factors of en bloc resection and complications CONCLUSIONS: ESD is an effective and safe therapy in the management of early gastric neoplasms when performed by well-trained endoscopists. Endoscopists should recognize the difficulty to perform ESD for en bloc resection of upper lesion, and the risk of delayed bleeding in cases of lesions >2 cm in size.
Asunto(s)
Adenocarcinoma/cirugía , Disección/efectos adversos , Endoscopía Gastrointestinal/efectos adversos , Mucosa Gástrica/cirugía , Neoplasias Gástricas/cirugía , Adenocarcinoma/patología , Anciano , Disección/métodos , Detección Precoz del Cáncer , Endoscopía Gastrointestinal/métodos , Estudios de Factibilidad , Femenino , Mucosa Gástrica/patología , Humanos , Complicaciones Intraoperatorias , Japón , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias , Complicaciones Posoperatorias , Neoplasias Gástricas/patología , Resultado del TratamientoRESUMEN
BACKGROUND: Patients with hepatocellular carcinoma (HCC) sometimes suffer from obscure gastrointestinal bleeding. Portal hypertension (PH), common in cirrhosis, induces esophagogastric varices. Because of the location, PH also may influence mucosal abnormalities in the small intestine. The objective of this study is to estimate the prevalence of small intestinal mucosal abnormalities in HCC patients using capsule endoscopy (CE). PATIENTS AND METHODS: We prospectively conducted CE in HCC patients, and analyzed the findings in relation to hepatic function, the number and size of HCC tumor and findings obtained by conventional endoscopy. RESULTS: Thirty-six patients (aged 66.7 ± 7.5 years, 29 men) underwent CE. Abnormal findings in the small bowel were found in 16 patients (44%), angioectasias in eight patients (22%), erosions in five (14%), varices in four (11%), polyps in four (11%), and submucosal tumor in one (3%). The patients with angioectasia had a larger spleen index than the no abnormal lesions group (85.4 ± 15.8 vs 59.0 ± 24.4, P = 0.02). The former group had been more frequently treated for esophageal varices endoscopically (62% vs 15%, P = 0.02). Large HCC nodules seemed more common in the patients with angioectasia than subjects without abnormal lesions (38% vs 5%, P = 0.06). Small intestinal varices also seemed to have a positive association with large HCC. During the follow up after CE, one patient with small intestinal polyps suffered from obscure gastrointestinal bleeding. CONCLUSIONS: CE revealed that HCC patients frequently have small intestinal mucosal lesions. In particular, small intestinal angioectasia, which may cause obscure gastrointestinal bleeding, seems to be associated with portal hypertension.
Asunto(s)
Endoscopía Capsular , Carcinoma Hepatocelular/diagnóstico , Enfermedades Intestinales/diagnóstico , Neoplasias Intestinales/diagnóstico , Intestino Delgado/patología , Neoplasias Hepáticas/diagnóstico , Anciano , Angiodisplasia/diagnóstico , Angiodisplasia/patología , Carcinoma Hepatocelular/patología , Estudios Transversales , Femenino , Hemorragia Gastrointestinal/diagnóstico , Hemorragia Gastrointestinal/patología , Humanos , Hipertensión Portal/patología , Enfermedades Intestinales/patología , Mucosa Intestinal/patología , Neoplasias Intestinales/patología , Pólipos Intestinales/diagnóstico , Pólipos Intestinales/patología , Intestino Delgado/irrigación sanguínea , Pruebas de Función Hepática , Neoplasias Hepáticas/patología , Masculino , Persona de Mediana Edad , Neoplasias Primarias Múltiples/diagnóstico , Neoplasias Primarias Múltiples/patología , Vena Porta/patología , Estudios Prospectivos , Trombosis/diagnóstico , Trombosis/patología , Várices/diagnóstico , Várices/patologíaRESUMEN
Recent advances in colonoscopic techniques have resulted in more frequent detection of superficial-type colorectal tumors, that is, laterally spreading tumors (LSTs), although little is known about the characteristic clinical features and genetic alterations of LSTs. To elucidate the molecular characteristics of LSTs, genetic alterations in the KRAS, BRAF and PIK3CA genes and abnormal expression of the p53, beta-catenin and MYC proteins were analyzed using direct DNA sequencing and immunohistochemistry for 50 protruded-type tumors (Protruded), 35 granular-type LSTs (LST-G) and 19 nongranular-type LSTs (LST-NG). In addition, loss of heterozygosity (LOH) close to the adenomatous polyposis coli (APC) gene (5q21) was examined in these tumors. In univariate analyses, significant differences were noted in the percentages with KRAS mutations (Protruded, LST-G, LST-NG = 30.0%, 54.3%, 21.1%, respectively, p = 0.0156), nuclear accumulation of beta-catenin (Protruded, LST-G, LST-NG = 50.0%, 37.1%, 68.4%, respectively, p = 0.0267), expression of MYC (Protruded, LST-G, LST-NG = 26.0%, 17.1%, 42.1%, respectively, p = 0.0456) and LOH at the APC gene locus (Protruded, LST-G, LST-NG = 22.0%, 20.0%, 47.4%, respectively, p = 0.0302). Multivariate analysis demonstrated that the macroscopic subtype of LST was significantly associated with KRAS mutation (for LST-NG: odds ratio [OR] 0.23, 95% CI 0.06-0.90) and nuclear accumulation of beta-catenin (for LST-NG: OR 4.05, 95% CI 1.11-14.8). Our data revealed that the 2 subtypes of LST have different molecular characteristics, suggesting that 2 or more different molecular mechanisms result in colorectal tumors with a similar growth pattern.
Asunto(s)
Neoplasias Colorrectales/genética , Neoplasias Colorrectales/patología , Proteínas Proto-Oncogénicas B-raf/genética , Adenoma/enzimología , Adenoma/genética , Adenoma/patología , Anciano , Cromosomas Humanos Par 5 , Neoplasias Colorrectales/enzimología , Análisis Mutacional de ADN , Cartilla de ADN , ADN de Neoplasias/genética , Femenino , Genes p53 , Genes ras , Humanos , Pérdida de Heterocigocidad , Masculino , Persona de Mediana Edad , Metástasis de la Neoplasia , Fosfatidilinositol 3-Quinasas/genética , Proteínas Proto-Oncogénicas c-myc/genética , beta Catenina/genéticaRESUMEN
OBJECTIVES: The aim of this study was to elucidate the association between body mass index (BMI) and both Helicobacter pylori and atrophic gastritis. METHODS: The study involved 10,197 subjects participating in a Japanese mass endoscopic gastric cancer screening program. Atrophic gastritis was assessed by pepsinogen I to II ratio. RESULTS: In logistic regression models, BMI had an inverse association with atrophic gastritis, with the odds ratios (OR) decreasing progressively to 0.67 (95% confidence interval [CI] 0.57-0.79, P<0.0001) in the highest BMI quintiles (BMI >or=25.66) group compared with the lowest BMI quintiles (BMI <20.97) group. In linear regression models, atrophic gastritis predicted BMI (regression coefficient -0.326, 95% CI -0.469, -0.184, P<0.0001), whereas H. pylori antibody was not a predictor (regression coefficient 0.072, 95% CI -0.053, 0.198, P=0.3). CONCLUSIONS: A small, inverse association between BMI and atrophic gastritis was found in the general population. In contrast, no association was observed between H. pylori seropositivity and BMI.
Asunto(s)
Pueblo Asiatico , Índice de Masa Corporal , Gastritis Atrófica/fisiopatología , Infecciones por Helicobacter/fisiopatología , Helicobacter pylori/aislamiento & purificación , Adulto , Factores de Edad , Anticuerpos Antibacterianos/sangre , Pueblo Asiatico/estadística & datos numéricos , Estudios Transversales , Femenino , Gastritis Atrófica/etnología , Gastritis Atrófica/etiología , Gastroscopía , Infecciones por Helicobacter/etnología , Infecciones por Helicobacter/etiología , Infecciones por Helicobacter/microbiología , Helicobacter pylori/inmunología , Humanos , Japón/epidemiología , Modelos Logísticos , Masculino , Tamizaje Masivo/métodos , Persona de Mediana Edad , Oportunidad Relativa , Pepsinógeno A/sangre , Pepsinógeno C/sangre , Medición de Riesgo , Factores de RiesgoRESUMEN
Preliminary observation of the flights of swallowtail butterfly Papilio xuthus revealed that its dihedral angle is larger than 30 degrees and that the section of its left hind wing close to its body and the counterpart of its right hind wing actually clap and form a "vertical tail". In this study, the effects of these two features on the lateral-directional dynamic flight stability of these butterflies were analyzed theoretically and revealed the following: (a) when the dihedral angle is larger than 30 degrees , the lateral-directional motion of the swallowtail becomes stable; (b) the vertical tail stabilizes the dutch roll mode; (c) the effects of the dihedral angle on the roll and spiral modes of a swallowtail are qualitatively the same as those of a meter-sized airplane; and (d) with increasing dihedral angle, the stability of the dutch roll mode decreases for a meter-sized airplane with vertical and horizontal tails but increases for the swallowtail. A possible explanation for the latter effect is the smaller Reynolds number of the insect that causes the drag coefficient of the swallowtail wings to increase more rapidly with an increasing angle of attack compared to a large airplane.
Asunto(s)
Mariposas Diurnas/fisiología , Vuelo Animal/fisiología , Alas de Animales/fisiología , Aeronaves , Animales , Fenómenos Biomecánicos , Mariposas Diurnas/anatomía & histología , Modelos Biológicos , Movimiento , Alas de Animales/anatomía & histologíaRESUMEN
OBJECTIVES: Obesity is thought to be associated with colorectal cancer and adenoma. We aimed to investigate the effect of body weight on the risk of colorectal adenoma both in cross-sectional and longitudinal analyses. METHODS: This is a retrospective cohort study in a large-scale health appraisal institution in Japan. A total of 7,963 asymptomatic, average-risk Japanese were enrolled at initial examinations, and 2,568 subjects who underwent a second colonoscopy after 1 yr were investigated. The association with the prevalence of colorectal adenoma was evaluated according to the body mass index (BMI) at the initial examination. The incidence of colorectal adenoma at the second colonoscopy was investigated according to the initial BMI and body weight changes during the year. RESULTS: The prevalence of colorectal adenoma increased in relation to increases in the BMI: 15.4%, 20.6%, 22.7%, and 24.2%, respectively, in the first (BMI < 21.350), second (21.350 < or = BMI < 23.199), third (23.199 < or = BMI < 25.156), and fourth (25.156 < or = BMI) quartiles. The adjusted odds ratios in reference to Group Q1 were 1.15 (95% CI 0.97-1.37, P= 0.1) for Group Q2, 1.19 (1.01-1.41, P= 0.04) for Group Q3, and 1.32 (1.12-1.56, P= 0.001) for Group Q4. The incidence rates of colorectal adenoma after 1 yr also increased proportionally according to the initial BMI: Group Q1 (12.9%), Group Q2 (15.7%), Group Q3 (18.3%), and Group Q4 (19.0%). CONCLUSIONS: Obesity was associated with the risk for colorectal adenoma, and body weight reduction was suggested to decrease this risk.
Asunto(s)
Adenoma/epidemiología , Neoplasias Colorrectales/epidemiología , Obesidad/complicaciones , Pérdida de Peso , Adulto , Índice de Masa Corporal , Estudios de Cohortes , Colonoscopía , Estudios Transversales , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Obesidad/patología , Prevalencia , Estudios RetrospectivosRESUMEN
OBJECTIVES: Postcholecystectomy patients show moderate risk of colorectal cancer. However, few studies have investigated the relationship between cholelithiasis and colorectal adenoma. We examined this possibility through a combination of colonoscopy and ultrasonography in asymptomatic Japanese. METHODS: We reviewed a subgroup of subjects drawn from a prospective annual colonoscopy screening survey. Subjects who underwent both ultrasonography and colonoscopy, and completed a questionnaire regarding lifestyle habits were entered. We investigated whether subjects with cholelithiasis or a previous cholecystectomy showed an increased risk of colorectal adenoma, as compared with subjects with normal gallbladders. RESULTS: Data of 4,458 subjects (men 3,053, women 1,405, mean age +/- SD 46.1 +/- 8.62 yr) were analyzed. Cholelithiasis was detected in 206 subjects, 4,189 subjects had normal gallbladders, and 63 subjects had cholecystectomies. The prevalence of colorectal adenoma was 29.6% (61/206) in subjects with cholelithiasis, which was significantly higher when compared with normal subjects, with a prevalence of 17.7% (741/4,189, P < 0.001). In cholecystectomy patients, only 15.9% (10/63) developed colorectal adenomas, which was not significantly different from the control group. In a multivariate analysis controlling for sex, age, family history of colorectal cancer, alcohol, smoking, and body mass index, cholelithiasis was shown to be an independent risk factor for colorectal adenoma (adjusted OR 1.57, 95% CI 1.14-2.18). Cholelithiasis was strongly associated with multiple (> or = 3 lesions, adjusted OR 2.39, 95% CI 1.21-4.72) and left-sided colorectal adenomas (adjusted OR 1.82, 95% CI 1.28-2.59). CONCLUSIONS: Cholelithiasis is a risk factor for colorectal adenoma.
Asunto(s)
Adenoma/etiología , Colelitiasis/complicaciones , Neoplasias Colorrectales/etiología , Humanos , Factores de RiesgoRESUMEN
Epidemiologically, the association between chronic Helicobacter pylori infection and development of gastric cancer is well established. Although the possibility of preventing gastric cancer by eradicating H. pylori infection was recently investigated by several research groups, the results remain controversial. The aim of this study was to determine whether the eradication of H. pylori infection would reduce the incidence of gastric cancer. In total, 304 patients with persistent H. pylori infection and 404 patients with H. pylori infection eradicated were examined annually for gastric cancer by endoscopy. Over an average of 3.1 years for the first group and 3.2 years for the second group, 13 and 6 patients, respectively, were diagnosed as having new gastric cancer. The cumulative incidence of gastric cancer was statistically different between the groups (P=0.019; log-rank test). The hazard ratio of H. pylori eradication was 0.335 by Cox proportional hazards model (P=0.047). Differentiated gastric cancer was found in 11 patients in the persistent infection group and 3 patients in the eradicated group. The incidence of differentiated cancer was significantly different (P=0.017) between the groups, but not for undifferentiated cancer (P=0.847). The results of the current study suggest that the eradication of H. pylori infection reduces the incidence of gastric cancer.